Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Exelixis
Exelixis
After a long march with Cabo, Exelixis is expanding its focus with an antibody-drug conjugate deal
Endpoints
Thu, 05/16/19 - 10:25 am
Exelixis
Cabometyx
ICON-2
Iconic Therapeutics
antibody-drug conjugate
Where Will Gilead Sciences Spend Its Cash?
Motley Fool
Tue, 05/7/19 - 10:03 am
Gilead Sciences
M&A
Atara
Exelixis
Exelixis initiates phase 3 trial of cabozantinib in advanced renal cell carcinoma
Pharmaceutical Business Review
Thu, 05/2/19 - 11:20 am
Exelixis
clinical trials
cabozantinib
Cabometyx
advanced renal cell carcinoma
3 Cancer Treatment Stocks on a Growth Trend
Motley Fool
Sun, 04/21/19 - 10:33 pm
Geron
AbbVie
Exelixis
cancer
Exelixis Proves Being Second Can Work Out Well
Motley Fool
Wed, 02/13/19 - 05:04 pm
Exelixis
Bristol-Myers Squibb
Cabometyx
kidney cancer
Exelixis (EXEL) to Report Q4 Earnings: What's in Store?
Yahoo/Zacks.com
Fri, 02/8/19 - 09:26 am
Exelixis
earnings
FDA approves Cabometyx for liver cancer
BioCentury
Mon, 01/14/19 - 11:59 pm
Exelixis
Ipsen
Cabometyx
liver cancer
FDA
Down but Not Out: 10 Biggest Drug Trials That Saw Challenges in 2018
BioSpace
Fri, 12/21/18 - 12:10 pm
clinical trials
Takeda
Zinfandel Pharmaceuticals
pioglitazone
Alzheimer's disease
Boehringer Ingelheim
BI 409306
Merck
verubecestat
Celgene
MS
ozanimod
Incyte
ID01
melanoma
vTv Therapeutics
azeliragon
Roche
Tecentriq
Exelixis
colorectal cancer
JNJ
atabacestat
Sareptat Therapeutics
DMD
Exondys 51
Alkermes
ALKS-5461
clinical depression
Exelixis Grabs Its Share of the Kidney-Cancer Treatment Market
Motley Fool
Tue, 11/6/18 - 09:34 am
Exelixis
earnings
kidney cancer
Cabometyx
Why Merck's Latest Success Means Trouble for Exelixis Inc.
Yahoo/Motley Fool
Fri, 10/19/18 - 09:13 am
Merck
Exelixis
Cabometyx
Keytruda
Exelixis Begins Ph III Trial of Cabometyx in Refractory Thyroid Cancer
CP Wire
Mon, 10/8/18 - 09:55 am
Exelixis
Cabometyx
thyroid cancer
Exelixis Begins Ph III Trial of Cabometyx in Refractory Thyroid Cancer
Mon, 10/8/18 - 09:25 am
Exelixis
Cabometyx
thyroid cancer
Exelixis and Ipsen Announce Positive CHMP Opinion for Cabometyx in Previously Treated Hepatocellular Carcinoma
CP WIre
Fri, 09/21/18 - 10:02 am
Exelixis
Ipsen
Cabometyx
hepatocellular carcinoma
Exelixis and Ipsen Announce Positive CHMP Opinion for Cabometyx in Previously Treated Hepatocellular Carcinoma
Fri, 09/21/18 - 10:01 am
Exelixis
Ipsen
Cabometyx
hepatocellular carcinoma
Canada Approves Cabometyx for Adults with Previously Treated Advanced Renal Cell Carcinoma
CP Wire
Wed, 09/19/18 - 11:27 am
Exelixis
Cabometyx
Takeda
Canada
Japan
Ipsen
renal cell carcinoma
Canada Approves Cabometyx for Adults with Previously Treated Advanced Renal Cell Carcinoma
Wed, 09/19/18 - 09:16 am
Exelixis
Ipsen
Cabometyx
National Comprehensive Cancer Network Releases New Guidelines for Cabometyx for Advanced Renal Cell Carcinoma
CP Wire
Fri, 09/7/18 - 11:05 am
Exelixis
Cabometyx
advanced renal cell carcinoma
National Comprehensive Cancer Network Releases New Guidelines for Cabometyx for Advanced Renal Cell Carcinoma
Fri, 09/7/18 - 09:44 am
Exelixis
Cabometyx
advanced renal cell carcinoma
Exelixis Gets the Patients Eventually
Motley Fool
Mon, 08/6/18 - 11:47 pm
Exelixis
kidney cancer
renal cell carcinoma
Cabometyx
Exelixis Expands Ph Ib Immunotherapy Trial to Include Additional Patients with Locally Advanced or Metastatic Solid Tumors
CP Wire
Fri, 06/1/18 - 09:55 am
Exelixis
clinical trials
Cabometyx
Tecentriq
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »